Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Objective. To evaluate the effectiveness and safety of coenzyme Q10 for patients with type 2 diabetes mellitus (T2DM). Methods. Data from randomized controlled trials were obtained to assess the effects of coenzyme Q10 versus placebo or western medicine on patients with T2DM. The study’s registration number is CRD42018088474. The primary outcomes included glycosylated hemoglobin, fasting blood glucose, and fasting insulin. Result. Thirteen trials involving 765 patients were included. Compared with the control group, coenzyme Q10 may decrease the HbA1c (WMD −0.29; 95% CI −0.54, −0.03; P=0.03) and the fasting blood glucose (WMD −11.21; 95% CI −18.99, −3.43; P=0.005). For fasting insulin, there is also not strong evidence that confirms which one is better because there was no statistical difference (WMD −0.48; 95% CI −2.54, 1.57; P=0.65). Conclusion. Based on current evidence, coenzyme Q10 may assist glycemic control, decrease TG, and improve HDL-C in patients with T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous studies have shown that the intake of exogenous CoQ10 could help to prevent the progression of illness, such as heart failure, metabolic syndrome, NAFLD, diabetes mellitus, and several neurodegenerative diseases177,181–186.”
From Key points for the development of antioxidant cocktails to prevent cellular stress and damage caused by reactive oxygen species (ROS) during manned space missions (2021) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CoQ10 is an abundant lipid-soluble nutrient scavenging free radical and protecting cells against oxidative damage (Zhang et al., 2018).”
From Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact (2020) · cites this paper as Zhang et al., 2018
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 1×
“5 million deaths in 2012 as it relates to increased risk of cardiovascular and other diseases [4, 5].”
BackgroundBetter Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593 · cited 1×
“Future clinical trials are required to report AEs with more explanations [42].”
BackgroundMortality and cardiovascular disease in type 1 and type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608664 · Cited by 1,389 · cited 1×
“5 million deaths in 2012 as it relates to increased risk of cardiovascular and other diseases [4, 5].”
BackgroundHodgson, J., Watts, G., Playford, D., Burke, V, & Croft, K. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601464 · Cited by 252
Román-Pintos, L. M., Villegas-Rivera, G., Rodríguez-Carrizalez, A. D., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3425617 · Cited by 248 · cited 2×
“[15] found that coenzyme Q10 levels in T2DM patients were significantly lower than those in healthy people, while their MDA levels were significantly Random sequence generation (selection bias)”
BackgroundSimultaneous Detection of Ubiquinol and Ubiquinone in Human Plasma as a Marker of Oxidative Stress
Yamashita, S., & Yamamoto, Y. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2187 · Cited by 219 · cited 1×
“The ubiquinol/ubiquinone ratio is often utilized as an indicator to react to the body’s oxidative stress [38].”
MethodUse of Antioxidant Nutrients in the Prevention and Treatment of Type 2 Diabetes
Ruhe, R. C., & McDonald, R. B. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719169 · Cited by 134 · cited 1×
“T2DM occurs when the organism fails to respond to the increased blood glucose caused by the impaired β cell secretion and/or insulin resistance [1, 8].”
BackgroundPlayford, D. A., Watts, G. F., Croft, K. D., & Burke, V. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00417-3 · Cited by 98
15. Diabetes Advocacy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s015 · Cited by 97 · cited 1×
“At present, the treatment of diabetes is still lacking etiological treatment; the treatment of diabetes is mainly achieved through diabetes management including healthy eating, weight control, appropriate physical activity, antiglycemic medications, and multifactorial risk reduction [7].”
BackgroundAlam, M. A., & Rahman, M. M. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-60 · Cited by 91 · cited 1×
“Therefore, exogenous coenzyme Q10 supplements may improve the oxidative stressinduced abnormalities in mitochondrial functions, thereby bettering glycemic control in patients with T2DM [20].”
Background
Research works printed but not linked: 4
- Deeks J. J. Higgins J. P. Altman D. G. Higgins J. P. Green S. Chapter 16: special topics in statistics Cochrane Handbook for Systematic Reviews of Interventions 2011 UK The Cochrane Collaboration
- Deeks J. J. Higgins J. P. Altman D. G. Higgins J. P. Green S. Chapter 8: assessing risk of bias in included studies Cochrane Handbook or Systematic Reviews of Interventions Version 5.1.0 2011 UK The Cochrane Collaboration
- Deeks J. J. Higgins J. P. Altman D. G. Higgins J. P. Green S. Chapter 9: analyzing data and undertaking meta-analyses Cochrane Handbook for Systematic Reviews of Interventions 2011 UK The Cochrane Collaboration
- Loke Y. Price D. Herxheimer A. JPT H. Green S. Chapter 14: adverse effects Cochrane Handbook for Systematic Reviews of Interventions. Chapter 14 2011 Chichester, UK John Wiley & Sons
Cited by
da Silveira, W. A., Fazelinia, H., Rosenthal, S. B., Laiakis, E. C., Kim, M. S., Meydan, C., Kidane, Y., Rathi, K. S., Smith, S. M., Stear, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.002 · Cited by 402
“CoQ10 is an abundant lipid-soluble nutrient scavenging free radical and protecting cells against oxidative damage (Zhang et al., 2018).”
Metabolic and Vascular Effect of the Mediterranean Diet
Tuttolomondo, A., Simonetta, I., Daidone, M., Mogavero, A., Ortello, A., & Pinto, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194716 · Cited by 269
“[157] conducted a study that evaluated endothelial function in healthy patients with high lipid levels who practiced a Mediterranean diet.”
An integrative collaborative care model for people with mental illness and physical comorbidities
Ee, C., Lake, J., Firth, J., Hargraves, F., de Manincor, M., Meade, T., Marx, W., & Sarris, J. J. (2020) · International Journal of Mental Health Systems · doi:10.1186/s13033-020-00410-6 · Cited by 197
Disorders of Human Coenzyme Q10 Metabolism: An Overview
Hargreaves, I., Heaton, R. A., & Mantle, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186695 · Cited by 182
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M., Carvalho, A. F., Bortolasci, C. C., Walder, K., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 113
Clinical Advances in Immunonutrition and Atherosclerosis: A Review
Ruiz-León, A. M., Lapuente, M., Estruch, R., & Casas, R. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00837 · Cited by 106
“(140) reported an improvement in glycemic control, and TG and HDL-C levels in patients with T2DM supplemented with CoQ10.”
BackgroundAntioxidant and Anti-Inflammatory Effects of Coenzyme Q10 Supplementation on Infectious Diseases
Sifuentes-Franco, S., Sánchez-Macías, D. C., Carrillo-Ibarra, S., Rivera-Valdes, J. J., Zúñiga, L. Y., & Sánchez-López, V. A. (2022) · Healthcare · doi:10.3390/healthcare10030487 · Cited by 107
Gómez, X., Sanon, S., Zambrano, K., Asquel, S., Bassantes, M., Morales, J. E., Otáñez, G., Pomaquero, C., Villarroel, S., Zurita, A., et al. (2021) · npj Microgravity · doi:10.1038/s41526-021-00162-8 · Cited by 92
Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?
Duan, J.-Y., Lin, X., Xu, F., Shan, S., Guo, B., Li, F., Wang, Y., Zheng, M.-H., Xu, Q.-S., Lei, L.-M., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701788 · Cited by 73
Coenzyme Q10 and Male Infertility: A Systematic Review
Salvio, G., Cutini, M., Ciarloni, A., Giovannini, L., Perrone, M., & Balercia, G. (2021) · Antioxidants · doi:10.3390/antiox10060874 · Cited by 71
“CoQ10 supplementation has demonstrated a beneficial effect on inflammatory and OS-related conditions, such as cardiac failure [33], coronary artery disease [34] and type 2 diabetes mellitus [35].”
BackgroundCoenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview
Mantle, D., & Hargreaves, I. (2019) · Antioxidants · doi:10.3390/antiox8020044 · Cited by 63
Abot, A., Fried, S. G., Cani, P. D., & Knauf, C. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0100 · Cited by 53
“A systematic review and meta-analysis from Zhang et al. (224) highlighted that coenzyme Q10 supplementation in type 2 diabetic patients improves fasting glycemia.”
Liang, Y. J., Zhao, D., Ji, Q., Liu, M., Dai, S., Hou, S., Liu, Z., Mao, Y.-H., Tian, Z., & Yang, Y. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101602 · Cited by 51
Effect of Coenzyme Q10 Supplementation on Testosterone
Banihani, S. A. (2018) · Biomolecules · doi:10.3390/biom8040172 · Cited by 49
“Coenzyme Q10 has been used as an attractive intervention approach in a wide-range of pathological diseases or disorders, such as cardiovascular disease [7,8], diabetes [9,10], kidney disease [11], Parkinson’s disease [12,13], Huntington’s disease [14], cancer [15,16], and infertility [17,18].”
BackgroundAmeliorative effects of ginsenosides on myelosuppression induced by chemotherapy or radiotherapy
He, M., Wang, N., Zheng, W., Cai, X., Qi, D., Zhang, Y., & Han, C. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113581 · Cited by 49
Zhang, T., He, Q., Liu, Y., Chen, Z., & Hu, H.-J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/4471944 · Cited by 47
Al-Kuraishy, H. M., Al-Gareeb, A. I., Shams, H. A., & Al-Mamorri, F. (2019) · Journal of Laboratory Physicians · doi:10.4103/jlp.jlp_123_19 · Cited by 41
“What’s more, the present study disclosed that metformin alone or combination with CoQ10 produced a significant effect in attenuation of endothelial dysfunction in patients with T2DM through the reduction of E‐selectin and sVCAM‐1 as presented by earlier study.[21]”
ResultDai, S., Tian, Z., Zhao, D., Liang, Y. J., Liu, M., Liu, Z., Hou, S., & Yang, Y. (2022) · Antioxidants · doi:10.3390/antiox11071360 · Cited by 40
“For instance, previous studies suggested that CoQ10 levels were significantly lower in T2D patients than those in healthy people and the levels could be restored through exogenous CoQ10 supplementation [76,77].”
Combined Supplementation of Coenzyme Q10 and Other Nutrients in Specific Medical Conditions
Tippairote, T., Bjørklund, G., Gasmi, A., Semenova, Y. M., Peana, M., Chirumbolo, S., & Hangan, T. (2022) · Nutrients · doi:10.3390/nu14204383 · Cited by 31
“A 2018 meta-analysis of 13 RCTs suggested the benefits of CoQ10 supplementation on glycemic and lipid profiles in type 2 diabetic patients [119].”
MethodStability of Reduced and Oxidized Coenzyme Q10 in Finished Products
Rakuša, Ž. T., Kristl, A., & Roškar, R. (2021) · Antioxidants · doi:10.3390/antiox10030360 · Cited by 26
Coenzyme Q10 Supplementation in Athletes: A Systematic Review
Fernandes, M. S. D. S., Fidelis, D. E. D. S., Aidar, F. J., Bădicu, G., Greco, G., Cataldi, S., Santos, G. C. J., de Souza, R. F., & Ardigò, L. P. (2023) · Nutrients · doi:10.3390/nu15183990 · Cited by 27
“Some systematic reviews have demonstrated the benefits of CoQ 10 supplementation in health and disease conditions [19–21].”
Wang, Y., & Hekimi, S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101680 · Cited by 25
Arafa, E. A., Hassanein, E. H. M., Ibrahim, N. A., Buabeid, M. A., & Mohamed, W. R. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111566 · Cited by 24
Kim, Y., Oh, Y. K., Lee, J., & Kim, E. Y. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01374-6 · Cited by 23
Gonzalez, D. E., Dickerson, B. L., Roberts, B. M., Kurtz, J. A., Waldman, H. S., Gonzalez, A. M., McAllister, M. J., Heileson, J. L., Bloomer, R. J., Arent, S. M., et al. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2629828 · Cited by 21
Systematic Review of Nutrition Supplements in Chronic Kidney Diseases: A GRADE Approach
Lin, P., Chou, C., Ou, S., Fang, T., & Chen, J.-S. (2021) · Nutrients · doi:10.3390/nu13020469 · Cited by 21
“CoQ10 generate adenosine triphosphate (ATP) energy to cell [67] and is most commonly used for an antioxidant that helps improve cardiovascular diseases [68,69], heart failure [70], diabetes [71], hypercholesterolemia [72], migraine headache [73], and many other conditions related to lower CoQ10 levels.”
BackgroundAmini, P., Sajedi, F., Mirjalili, M., Mohammadi, Y., & Mehrpooya, M. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03407-x · Cited by 20
Depletion and Supplementation of Coenzyme Q10 in Secondary Deficiency Disorders
Mantle, D., Turton, N., & Hargreaves, I. P. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2712322 · Cited by 19
Asadbegi, M., Komaki, H., Faraji, N., Azandaryani, M. T., Safari, S., Raoufi, S., Kourosh‐Arami, M., Golipoor, Z., & Komaki, A. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06338-2 · Cited by 18
Effect of Coenzyme Q10 Supplementation on Lipid and Glycaemic Profiles: An Umbrella Review
Patiño‐Cardona, S., Garrido‐Miguel, M., Pascual‐Morena, C., Berlanga‐Macías, C., Lucerón‐Lucas‐Torres, M., Alfaro-González, S., & Martínez‐García, I. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11120377 · Cited by 17
Huang, Q., Fang, Q., & Hu, Z. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0020 · Cited by 15
“125 JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE / JUL-SEP 2020 / VOL 8 |ISSUE 3 In addition, based on current evidence, coenzyme Q10 may assist FPG control, decrease triglycerides, and improve HDL cholesterol in patients with T2D.[76,77] But coenzyme Q10 cannot improve fasting insulin and BMI.”
BackgroundInfluentialGhanem, M., Heikal, L., Fattah, H. S. A., Ashwah, A. E., & Fliefel, R. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113059 · Cited by 17
“Recently, CoQ10 has gained attention for its therapeutic application for several disorders including cardiovascular diseases [13], inflammation [14], human fertility [15], and diabetes mellitus [16] In diabetes mellitus, CoQ10 helps to control blood glucose level and decrease glycosylated hemoglobin [17].”
BackgroundSamimi, F., Baazm, M., Nadi, Z., Dastghaib, S., Rezaei, M., & Mashayekhi, F. J. (2024) · PubMed Central · doi:10.30476/ijms.2023.100078.3222 · Cited by 14
“7 In this regard, for identification of the possible mechanisms involved in the antioxidant property of CoQ-10, the genes involved in this pathway must be determined to achieve new supplementary therapeutic alternatives for the treatment of diabetes.”
BackgroundInsights into the Sources, Structure, and Action Mechanisms of Quinones on Diabetes: A Review
Zhang, T., Li, M., Lu, J., Wang, J., Zhang, M., Panichayupakaranant, P., & Chen, H. (2025) · Molecules · doi:10.3390/molecules30030665 · Cited by 10
“Meat, fish, nuts, and certain oils represent the most abundant dietary sources of CoQ10, which may help control blood glucose, lower total cholesterol, and improve high-density lipoprotein cholesterol (HDL-C) in patients with T2DM [24,51].”
The effect of coenzyme Q10 plus trimetazidine on acute viral myocarditis treatment.
Yin, Y., Zeng, S.-L., Li, Y.-W., Wu, Z., Huang, D.-J., & Tang, H.-Z. (2021) · PubMed · Cited by 7
Casagrande, D. S., Waib, F. F., Elías, J., & Júnior, A. A. J. (2024) · Obesities · doi:10.3390/obesities4020011 · Cited by 6
“…the effects of CoQ10 on markers of diabetes mellitus type 2 (fasting glucose, HOMA IR and HOMA β , HbA1c, QUICKI, and insulin), found that supplementation can help control fasting blood glucose and HbA1c despite not significantly reducing any of the other glycemic control-related markers [15,25].”
BackgroundInvestigation of anti-diabetic effect of a novel coenzyme Q10 derivative
Tan, X., Yang, X., Xu, X., Peng, Y., Li, X., Deng, Y., Zhang, X., Qiu, W., Wu, D., Ruan, Y., et al. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1280999 · Cited by 5
Abe, Y., Nishiwaki, H., Suzuki, T., Noma, H., Watanabe, Y., Ota, E., & Hasegawa, T. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084088 · Cited by 5
“The criteria mention CoQ10 treatment as the intervention of interest and patients with CKD not treated with CoQ10 as the comparator group.”
The Metabolic effects of coenzyme Q10 in patients with Polycystic Ovary Syndrome
Bader, S. A., Althanoon, Z. A., & Raoof, H. S. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00194 · Cited by 4
Collares, L. F., Messenburger, G. P., Nuñez, F. F., & Pieniz, S. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2624477 · Cited by 4
“In another meta-analysis, (Zhang et al. 2018) analyzed 13 RCTs ( n = 765) conducted exclusively in T2DM populations and reported greater reductions in FBG (−11.2 mg/ dL; 95% CI −17.4 to −5.0) and HbA1c (−0.29%; 95% CI −0.45 to −0.13) than those found in the current analysis.”
InfluentialBeeraka, N. M., Константиновна, Т. И., Алексеевна, Б. Г., Zhaburina, M. V., Nikolenko, V. N., Sinelnikov, M. Y., & Михалева, Л. М. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210810142527 · Cited by 3
Heshmat‐Ghahdarijani, K., Rad, M. R., Nasr, N., Baghaei, Z., & Dabaghi, G. G. (2024) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-024-01053-3 · Cited by 2
Ghiasi, S., Bashiri, J., Pourrazi, H., & Jadidi, R. P. (2022) · Sport Sciences for Health · doi:10.1007/s11332-022-00922-3 · Cited by 2
Katzinger, J. J., Mischley, L. K., & Allen, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00068-6 · Cited by 2
Musazadeh, V., Falahatzadeh, M., Mahmoudinezhad, M., shahhosseini, E., Jamali, M., Pam, P., & Shidfar, F. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70182 · Cited by 3
Co-enzyme Q10 in Diabetic Neuropathy: Mechanisms of Action and Clinical Evidence
Devhare, L., Kumar, Y. G., Priya, S., Verma, A., Dubey, M., & Aparna, T. N. (2026) · Springer eBooks · doi:10.1007/978-981-95-9326-2_16 · Cited by 1
Ghiasi, S., Bashiri, J., Pourrazi, H., & Jadidi, R. P. (2021) · Gene Cell and Tissue · doi:10.5812/gct.115206 · Cited by 1
Télessy, I. G., Buttar, H. S., Wilson, D. W., & Okpala, C. O. R. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1091327 · Cited by 1
Vuković, M., Jovičić-Bata, J., Todorović, N., Puača, G., Vesković, D., Panić, J. Č., Dugandžija, T., & Lalic-Popovic, M. N. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2296963 · Cited by 1
“One meta-analysis 57 suggested that coenzyme Q10 could assist glycemic control, help decrease triglycerides, and improve HDL-C levels in patients with DM2, which might help ameliorate some of the patients’ health issues, especially DM complications.”
Coenzyme Q10 and Metabolic Syndrome
Hernández‐Camacho, J. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_11
Casagrande, D. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-11062021-075151
Die Mitochondriopathie Diabetes mellitus – Intervention mit (Mikro-)Nährstoffen: Update 2023
Gröber, U., & Friedrichsen, H.-P. (2023) · Zeitschrift für Orthomolekulare Medizin · doi:10.1055/a-2184-1916
A CoQ10 terápiás-, prevenciós- és sportteljesítményre vonatkozó bizonyított hatásai
Maszlag, A., Mayer, L., & Fritz, P. (2024) · Recreation · doi:10.21486/recreation.2024.14.1.1
Rezagholizadeh, F., Rezvani, S., Oskouie, F. H., Bahreini, N., Arabi, S. M., Sadeghian, R., Fakhari, H., Bagheri, R., Ashtary‐Larky, D., Rastgoo, E., et al. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-01002-1
“The effect of CoQ10 supplementation on lipoproteins and lipids is dissimilar in the recent RCTs and meta-analyses [52], but CoQ10 supplementation had a positive efficacy on HDL, LDL, TG, and TC in recent studies [47, 48].”
Supportive and Palliative Care in Diabetes
Pravinkumar Vishwanath Ingle, N. B. M. N., Najib, N. B. M., Ng, R. Y., Ng, P. K., Ng, J. J., Ngiam, J. Y., Ng, E. P., & Srivastav, S. (2025) · The Review of Diabetic Studies · doi:10.70082/zaswgz42
Mustafa, R. S., & Al-Thanoon, Z. A. (2024) · The Review of Diabetic Studies
Metadata
- Authors
- Zhang, S.-Y., Yang, K.-L., Zeng, L.-T., Wu, X.-H., & Huang, H.-Y.
- Affiliations
- Hunan University of Chinese Medicine, Changsha 410208, China
- Jiangxi Provincial People’s Hospital, Nanchang 330006, China
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2018-09-16
- Volume
- 2018
- Pages
- 1-11
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- PMC
- PMC6165589
- OpenAlex
- W2890146747
- Cited by
- 51
- References
- 35
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 5 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 8 · 2019: 5 · 2018: 1
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81373551, 20134323110001, S2014S2032)
- Ministry of Education of the People’s Republic of China (81373551, 20134323110001, S2014S2032)
- Hunan Provincial Science and Technology Department (81373551, 20134323110001, S2014S2032)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- coenzyme Q10, type 2 diabetes, glycemic control, HbA1c, fasting blood glucose, fasting insulin, lipid profile, HDL cholesterol, triglycerides, dietary supplementation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.